Purchase Order HHSN272201401061P
Award Date 9/9/14
Potential Completion Date 10/9/14
Potential Value $94K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents, for the delivery of a MiSeq System sequencer. The award does not have a set-aside designation and has a ceiling value of $95,931. Illumina has a history of providing sequencing systems and related products and services to...
- This $95,931 firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. for a MiSeq High Throughput Sequencer System. The award did not have a set-aside designation. The MiSeq system will be used in NIAID's Laboratory of Immunoregulation and must be fully compatible with Illumina's existing on-site software, kits, and reagents. Illumina has a history of providing...
- This is a $95,931 firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. The contract is for the provision of an AMBIS # 1776240 MISEQ2 system, which supports genomic sequencing and analysis capabilities. Illumina is a leading manufacturer of sequencing and array-based solutions used to support life science research, applied markets, and molecular diagnostics....
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract, valued at $15,500.00, is for the delivery of AMBIS#1696270MISEQ-COMPREHENSIVE, a product that likely includes Illumina's MiSeq sequencing system, reagents, and related consumables. This contract was...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. for an MISEQ2 automated DNA sequencing system. The $90,882 contract does not have a set-aside designation. Illumina is a manufacturer and provider of genetic analysis instruments and reagents, and has previously received awards from federal agencies like the NIH, CDC, USDA, and VA to support genomic...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. for the purchase of a MiSeq System sequencing platform. The contract has a ceiling value of $95,931.00 and a completion date of August 21, 2014. Illumina is a manufacturer of sequencing and genomic analysis instruments and reagents that has previously provided such products and services to various federal...
- This is a $863,550.00 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) within the National Institutes of Health (NIH) to Illumina, Inc. for the provision of lab equipment, including NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, reagents, and other consumables. Illumina is a manufacturer and provider of genomic sequencing and analysis solutions. The award has no set-aside designation. Illumina has a history of providing...
- This is a $6,935.22 firm fixed-price purchase order contract awarded to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions, by the National Institute of Allergy and Infectious Diseases (NIAID), an agency of the National Institutes of Health (NIH). The contract, which has no set-aside designation, is for the provision of sequencing systems, reagents, and services to support genomic research and diagnostics across various federal agencies. Illumina has...
- This firm fixed-price delivery order was awarded by the National Institutes of Health (NIH) National Institute of Environmental Health Sciences to Illumina, Inc., a manufacturer of genetic sequencing systems and related products. The $115,493.42 award does not have a set-aside designation. Illumina has previously provided sequencing instruments, reagents, and services to support genomic research and analysis for various federal agencies like the NIH, Centers for Disease Control and Prevention,...
- This firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. for a one-year comprehensive plan to provide HiSeq 2000, cBOT, and MiSeq systems. The $100,884 contract does not include a set-aside provision. Illumina is a manufacturer of genetic sequencing and analysis instruments and reagents that have been utilized across various federal agencies, including the Centers...